Jul 2026· International Journal of Science and Research Archive· 0 citations
TL;DR
It is recommended that healthcare systems adopt XGBoost-based predictive models in clinical decision support tools for early screening, while future studies should validate these models using real-world clinical data to enhance reliability and generalizability.
Abstract
This study addresses the challenge of delayed diagnosis of diabetes, a condition that often leads to severe complications if not detected early. The primary objective is to evaluate and compare the performance of three machine learning classifiers XGBoost, Support Vector Machine (SVM), and Random Forest for early diabetes prediction using clinical and lifestyle data. The study utilizes the Diabetes Health Indicators dataset, which includes features such as body mass index (BMI), blood pressure, cholesterol levels, and physical activity. The dataset was sourced from a publicly available repository and preprocessed through handling missing values, feature scaling, and encoding categorical variables. The models were trained on the processed dataset and evaluated using accuracy, precision, recall, and F1-score metrics, alongside exploratory data analysis to understand feature relationships. Results show that all three models performed effectively, with XGBoost achieving the highest accuracy of 85.11%, followed by SVM at 84.82%, and Random Forest at 83.16%. These findings highlight the strength of ensemble and boosting techniques in handling complex health data and accurately predicting diabetes risk. In conclusion, machine learning models demonstrate strong potential for supporting early diabetes diagnosis and improving clinical decision-making. It is recommended that healthcare systems adopt XGBoost-based predictive models in clinical decision support tools for early screening, while future studies should validate these models using real-world clinical data to enhance reliability and generalizability.
This study investigated the application of machine learning techniques and exploratory data analysis to forecast early-onset of diabetes using the PIMA Indian dataset, finding promising results.
Abdulrahman Nasiru Sada, Eli. A. Jiya, Yahaya Muhammad Umar et al.· Journal of Science Research...· 0 citations
Evaluated machine learning algorithms for predicting diabetes risk from routinely available clinical and lifestyle variables confirm that ensemble tree-based methods, particularly Random Forest, provide a reliable, interpretable, and deployable basis for diabetes risk screening, especially in resource-constrained setti...
T. Olayinka· FUDMA Journal of Sciences· 0 citations
Random Forest provided the best overall performance for three-class diabetes classification in this analytical sample, however, modest agreement, low prediabetes sensitivity, potential label leakage from fasting glucose, and the absence of external validation indicate that further evaluation is required before clinical...
Ayeni Taiwo Michael, Odukoya Ayooluwa, Ilesanmi Opeyemi· Asian Research Journal of Ma...· 0 citations
Experimental results demonstrate that Machine Learning techniques can effectively predict disease occurrence with high accuracy, thereby assisting healthcare professionals in early diagnosis and treatment planning.
Sunidhi, Rahul, Parmod Kumar et al.· International Journal for Re...· 0 citations
Diabetes is a chronic metabolic disease characterized by high blood glucose levels that can lead to severe complications affecting various organs. The increasing prevalence of diabetes requires an accurate and efficient diagnostic approach to support early detection and medical decision-making. The development of machi...
Basyach Aryodito Tranggono Heryanto, Onny Marleen· Journal of social research· 0 citations
Findings suggest that Random Forest and Logistic Regression are the most promising for assisting in preliminary diabetes prediction, although further validation on diversity datasets is needed prior to clinical deployment.
F. Setiawan, Tri Sugihartono· SinkrOn· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.